喘息型慢性支气管炎硝苯地平控释片和舒氟美联合治疗

Chronic asthmatic bronchitis and nifedipine GITS Shu-US joint fluoride treatment

目的:观察硝苯地平控释片与舒氟美联合使用对喘息型慢性支气管炎的疗效。方法:选择喘息型慢性支气管炎137例,随机分成两组,治疗组72例,口服硝苯地平控释片(每次30mg,1次/d)与舒氟美(100mg,1次/2h);对照组65例,口服舒氟美(100mg,1次/12h),其它辅助治疗方法相同,1周为1个疗程。结果:治疗组患者咳嗽、喘息和哮鸣音的显效率分别达到36.1%、37.5%和34.7%,与对照组比较有显著性差异(P<0.05),总有效率分别达到93.1%、94.4%和93.1%,与对照组比较有极显著性差异(P<0.01)。结论:硝苯地平控释片与舒氟美联合使用对喘息型慢性支气管炎有良好的治疗作用。

Purpose： observation of nifedipine GITS and sulpiride the use of fluoride - US joint chronic asthmatic bronchitis effect. Methods chronic asthmatic bronchitis 137 cases were randomly divided into two groups of 72 cases, oral nifedipine （30 mg each, 1 / d） and sulpiride fluoride United States （100 mg, 1 / 12 h）, the control group of 65 cases, oral fluoride US Shu （100 rng, 1 / 12 h）, other adjuvant therapy for the same treatment for a week. Results： the Treatment group patients cough, breathing and Wheezing sound significant efficiency reached 36.1%, 37.5 % and 34.7 %, compared with the control group there were significant differences （P 〈 0.05）, and the total efficiency reached 93.1%, 94.4 % and 93.1%, compared with the control group was significant difference （P 〈0.01 ）. Conclusion：Shu nifedipine and the use of fluoride- US joint chronic asthmatic bronchitis good therapeutic effect.